TSHA position history
The shares of Taysha Gene Therapies (TSHA) that Palo Alto Investors LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2023 Q4: 1,059,722 shares, $1.9M, 0.17% of portfolio, New
- 2024 Q1: 811,268 shares, $2.3M, 0.26% of portfolio, Reduce −23.4%
- 2024 Q2: 811,268 shares, $1.8M, 0.21% of portfolio
- 2024 Q3: 811,268 shares, $1.6M, 0.21% of portfolio
- 2024 Q4: 811,268 shares, $1.4M, 0.22% of portfolio
- 2025 Q1: 1,419,468 shares, $2M, 0.38% of portfolio, Add +75.0%
- 2025 Q2: 1,246,033 shares, $2.9M, 0.61% of portfolio, Reduce −12.2%
- 2025 Q3: 1,246,033 shares, $4.1M, 0.75% of portfolio
- 2025 Q4: 1,183,195 shares, $6.5M, 0.91% of portfolio, Reduce −5.0%
- 2026 Q1: 1,391,382 shares, $6.2M, 0.95% of portfolio, Add +17.6%
- 2026 Q2: 1,391,382 shares, $9.5M, 1.3% of portfolio
- 2026 Q3: 1,337,217 shares, $6.5M, 0.97% of portfolio, Reduce −3.9%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|